U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07892287) titled 'Effect of Neurofeedback and TMS' on Sept. 16.
Brief Summary: The goal of this clinical trial is to is to learn whether adding EEG neurofeedback (NFB) to repetitive transcranial magnetic stimulation (rTMS) is safe and feasible for adults with major depressive disorder (MDD). The study will also explore whether combining NFB with TMS may improve depression symptoms and change brain activity related to mood, focus, and rumination. The main questions it aims to answer are:
* Is alpha-down neurofeedback safe, tolerable, and feasible for people with MDD?
* Does alpha-down neurofeedback improve symptoms of depression, anxiety, and diffic...